• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Percutaneous transluminal angioplasty in patients with multivessel coronary disease: how important is complete revascularization for cardiac event-free survival?

作者信息

Bell M R, Bailey K R, Reeder G S, Lapeyre A C, Holmes D R

机构信息

Division of Cardiovascular Diseases and Internal Medicine, Mayo Clinic, Rochester, Minnesota 55905.

出版信息

J Am Coll Cardiol. 1990 Sep;16(3):553-62. doi: 10.1016/0735-1097(90)90342-m.

DOI:10.1016/0735-1097(90)90342-m
PMID:2387928
Abstract

The relative influences of revascularization status and baseline characteristics on long-term outcome were examined in 867 patients with multivessel coronary disease who had undergone successful coronary angioplasty. These patients represented 83% of a total of 1,039 patients in whom angioplasty had been attempted with an in-hospital mortality and infarction rate of 2.5% and 4.8%, respectively. Emergency coronary bypass surgery was needed in 4.9%. Of the 867 patients, 41% (group 1) were considered to have complete revascularization and 59% (group 2) to have incomplete revascularization. Univariate analysis revealed major differences between these two groups with patients in group 2 characterized by advanced age, more severe angina, a greater likelihood of previous coronary surgery and infarction, more extensive disease and poorer left ventricular function. Over a mean follow-up period of 26 months, the probability of event-free survival was significantly lower for group 2 only with respect to the need for coronary artery surgery (p = 0.004) and occurrence of severe angina (p = 0.04). The difference in mortality was of borderline significance (p = 0.051) and there were no significant differences between groups 1 and 2 in either the incidence of myocardial infarction or the need for repeat angioplasty. Multivariate analysis identified independent baseline predictors of late cardiac events that were then used to adjust the probabilities of event-free survival. This adjustment effectively removed any significant influence of completeness of revascularization on event-free survival for any of the above end points including the combination of death, myocardial infarction and need for coronary artery surgery. Therefore, late outcome in these patients is not significantly influenced by revascularization status but depends more on baseline patient characteristics.

摘要

相似文献

1
Percutaneous transluminal angioplasty in patients with multivessel coronary disease: how important is complete revascularization for cardiac event-free survival?
J Am Coll Cardiol. 1990 Sep;16(3):553-62. doi: 10.1016/0735-1097(90)90342-m.
2
Is traditionally defined complete revascularization needed for patients with multivessel disease treated by elective coronary angioplasty? Multivessel Angioplasty Prognosis Study (MAPS) Group.
J Am Coll Cardiol. 1993 Nov 1;22(5):1289-97. doi: 10.1016/0735-1097(93)90532-6.
3
Argentine randomized trial of percutaneous transluminal coronary angioplasty versus coronary artery bypass surgery in multivessel disease (ERACI): in-hospital results and 1-year follow-up. ERACI Group.阿根廷多支血管病变患者经皮腔内冠状动脉成形术与冠状动脉搭桥手术对比的随机试验(ERACI):住院结果及1年随访。ERACI研究组
J Am Coll Cardiol. 1993 Oct;22(4):1060-7. doi: 10.1016/0735-1097(93)90416-x.
4
Three-year follow-up of the Argentine Randomized Trial of Percutaneous Transluminal Coronary Angioplasty Versus Coronary Artery Bypass Surgery in Multivessel Disease (ERACI).
J Am Coll Cardiol. 1996 Apr;27(5):1178-84. doi: 10.1016/0735-1097(95)00592-7.
5
Is a strategy of intended incomplete percutaneous transluminal coronary angioplasty revascularization acceptable in nondiabetic patients who are candidates for coronary artery bypass graft surgery? The Bypass Angioplasty Revascularization Investigation (BARI).对于适合冠状动脉旁路移植手术的非糖尿病患者,意向性不完全经皮腔内冠状动脉血管成形术血运重建策略是否可接受?旁路血管成形术血运重建调查(BARI)。
J Am Coll Cardiol. 1999 May;33(6):1627-36. doi: 10.1016/s0735-1097(99)00077-7.
6
Importance of diabetes mellitus and systemic hypertension rather than completeness of revascularization in determining long-term outcome after coronary balloon angioplasty (the LDCMC registry). Lady Davis Carmel Medical Center.糖尿病和系统性高血压在决定冠状动脉球囊血管成形术(LDCMC注册研究)后的长期预后中的重要性,而非血管重建的完整性。戴维斯夫人卡梅尔医疗中心。
Am J Cardiol. 1998 Sep 1;82(5):547-53. doi: 10.1016/s0002-9149(98)00413-5.
7
Revascularization therapy for coronary artery disease. Coronary artery bypass grafting versus percutaneous transluminal coronary angioplasty.冠状动脉疾病的血运重建治疗。冠状动脉旁路移植术与经皮腔内冠状动脉成形术。
Tex Heart Inst J. 1995;22(2):145-61.
8
Prospective case-control comparison of percutaneous transluminal coronary revascularization in patients with multivessel disease treated in 1986-1987 versus 1991: improved in-hospital and 12-month results. Multivessel Angioplasty Prognosis Study (MAPS) Group.
J Am Coll Cardiol. 1995 Apr;25(5):1137-42. doi: 10.1016/0735-1097(94)00541-w.
9
Percutaneous transluminal coronary angioplasty failures in patients with multivessel disease. Is there an increased risk?多支血管病变患者经皮腔内冠状动脉成形术失败情况。风险是否增加?
J Thorac Cardiovasc Surg. 1995 Jul;110(1):214-21; discussion 221-3. doi: 10.1016/S0022-5223(05)80028-5.
10
Long-term outcome of unsuccessful percutaneous transluminal coronary angioplasty.经皮腔内冠状动脉成形术失败后的长期预后
Am Heart J. 1990 Apr;119(4):791-6. doi: 10.1016/s0002-8703(05)80313-8.

引用本文的文献

1
Target Vessel Versus Complete Revascularization in Non-ST Elevation Myocardial Infarction Without Cardiogenic Shock.非ST段抬高型心肌梗死且无心源性休克患者的靶血管血运重建与完全血运重建对比
Cureus. 2022 Mar 14;14(3):e23139. doi: 10.7759/cureus.23139. eCollection 2022 Mar.
2
Differential Clinical Outcomes Between Angiographic Complete Versus Incomplete Coronary Revascularization, According to the Presence of Chronic Kidney Disease in the Drug-Eluting Stent Era.药物洗脱支架时代,根据慢性肾脏病的存在情况,血管造影完全与不完全冠状动脉血运重建的临床转归差异。
J Am Heart Assoc. 2018 Feb 15;7(4):e007962. doi: 10.1161/JAHA.117.007962.
3
Revascularization in ischemic heart failure with reduced left ventricular ejection fraction. The impact of complete revascularization.
左心室射血分数降低的缺血性心力衰竭中的血运重建。完全血运重建的影响。
Kardiochir Torakochirurgia Pol. 2017 Mar;14(1):37-42. doi: 10.5114/kitp.2017.66928. Epub 2017 Mar 31.
4
Evaluation of clinical outcomes in patients undergoing dual vessel percutaneous coronary intervention using sirolimus-eluting coronary stent system in India.在印度使用西罗莫司洗脱冠状动脉支架系统进行双支血管经皮冠状动脉介入治疗的患者的临床结果评估。
J Clin Diagn Res. 2015 Feb;9(2):OC05-9. doi: 10.7860/JCDR/2015/10766.5525. Epub 2015 Feb 1.
5
Completeness of revascularisation by percutaneous coronary intervention.经皮冠状动脉介入治疗的血管再通完整性
Neth Heart J. 2001 Apr;9(1):3-9.
6
Recurrent angina after coronary angioplasty: mechanisms, diagnostic and therapeutic options.经皮冠状动脉介入治疗后心绞痛复发:机制、诊断和治疗选择。
Eur Heart J Acute Cardiovasc Care. 2012 Jun;1(2):158-69. doi: 10.1177/2048872612449111.
7
Impact of incomplete revascularization on long-term mortality after coronary stenting.支架置入术后冠状动脉血运重建不完全对长期死亡率的影响。
Circ Cardiovasc Interv. 2011 Oct 1;4(5):413-21. doi: 10.1161/CIRCINTERVENTIONS.111.963058. Epub 2011 Oct 4.
8
Immediate and long-term results of coronary angioplasty in patients aged 80 years and older.80 岁及以上患者经皮冠状动脉介入治疗的即刻和长期结果。
Cardiol Res Pract. 2010;2010:263685. doi: 10.4061/2010/263685. Epub 2010 Jun 20.
9
Effectiveness and cost effectiveness of single bolus treatment with abciximab (Reo Pro) in preventing restenosis following percutaneous transluminal coronary angioplasty in high risk patients.阿昔单抗(Reo Pro)单次推注治疗高危患者经皮腔内冠状动脉成形术后预防再狭窄的有效性及成本效益
Heart. 1998 Jan;79(1):12-7. doi: 10.1136/hrt.79.1.12.
10
Determinants of success of coronary angioplasty in patients with a chronic total occlusion: a multiple logistic regression model to improve selection of patients.慢性完全闭塞患者冠状动脉血管成形术成功的决定因素:一种用于改善患者选择的多元逻辑回归模型。
Br Heart J. 1993 Aug;70(2):126-31. doi: 10.1136/hrt.70.2.126.